The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts.

MLA

Smolich, B. D., et al. “The Antiangiogenic Protein Kinase Inhibitors SU5416 and SU6668 Inhibit the SCF Receptor (c-Kit) in a Human Myeloid Leukemia Cell Line and in Acute Myeloid Leukemia Blasts.” Blood, vol. 97, no. 5, Mar. 2001, pp. 1413–21. EBSCOhost, https://doi.org/10.1182/blood.v97.5.1413.

APA

Smolich, B. D., Yuen, H. A., West, K. A., Giles, F. J., Albitar, M., & Cherrington, J. M. (2001). The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts. Blood, 97(5), 1413–1421. https://doi.org/10.1182/blood.v97.5.1413

Chicago

Smolich, B D, H A Yuen, K A West, F J Giles, M Albitar, and J M Cherrington. 2001. “The Antiangiogenic Protein Kinase Inhibitors SU5416 and SU6668 Inhibit the SCF Receptor (c-Kit) in a Human Myeloid Leukemia Cell Line and in Acute Myeloid Leukemia Blasts.” Blood 97 (5): 1413–21. doi:10.1182/blood.v97.5.1413.